Aaron G.L. Fletcher

Insider Reports History

Location
40 Guest Street, Boston, MA
Signature
Aaron G.L. Fletcher By: /s/ John Fucci, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron G.L. Fletcher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 2.51M $23.1M $9.21 Jun 27, 2025 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 2.09M $19.3M $9.21 Jun 27, 2025 Directly held by Bios Actuate Co-Invest II, LP
Azitra Inc 10%+ Owner Common Stock 2.64M $13.2M $5.00 Jun 21, 2023 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 1.26M $11.6M $9.21 Jun 27, 2025 Directly held by Bios Clinical Opportunity Fund, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 980K $9.03M $9.21 Jun 27, 2025 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 573K $5.28M $9.21 Jun 27, 2025 Directly held by Bios Actuate Co-Invest III, LP
Azitra Inc 10%+ Owner Common Stock 1.02M $5.12M $5.00 Jun 21, 2023 Directly held by Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 2.02M $5.01M $2.48 Sep 19, 2025 By Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 526K $4.84M $9.21 Jun 27, 2025 Directly held by Bios Fund I, LP
Azitra Inc 10%+ Owner Common Stock 799K $4M $5.00 Jun 21, 2023 Directly held by Bios Fund I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 405K $3.73M $9.21 Jun 27, 2025 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 384K $3.53M $9.21 Jun 27, 2025 Directly held by Bios Fund III, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 1.42M $3.53M $2.48 Sep 19, 2025 By Bios Memory SPV I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 308K $2.83M $9.21 Jun 27, 2025 Directly held by Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 301K $2.77M $9.21 Jun 27, 2025 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 300K $2.76M $9.21 Jun 27, 2025 Directly held by Bios Fund II, LP
Cue Biopharma, Inc. Director Common Stock 940K $2.59M $2.76 May 24, 2022 Indirect
Azitra Inc 10%+ Owner Common Stock 468K $2.34M $5.00 Jun 21, 2023 Directly held by Bios Fund I QP, LP
Azitra Inc 10%+ Owner Common Stock 436K $2.18M $5.00 Jun 21, 2023 Directly held by Bios Azitra Co-Invest I, LP
Azitra Inc 10%+ Owner Common Stock 427K $2.13M $5.00 Jun 21, 2023 Directly held by Bios Fund III NT, LP
Azitra Inc 10%+ Owner Common Stock 405K $2.02M $5.00 Jun 21, 2023 Directly held by Bios Fund III, LP
Azitra Inc 10%+ Owner Common Stock 313K $1.57M $5.00 Jun 21, 2023 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 196K $1.37M $7.00 Jun 27, 2025 Directly held by Bios 2024 Co-Invest, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 500K $1.24M $2.48 Sep 19, 2025 By Bios Clinical Opportunity Fund, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 131K $1.21M $9.21 Jun 27, 2025 Directly held by Bios Fund II NT, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 373K $1.15M $3.09 Jun 13, 2025 By Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 419K $1.04M $2.48 Sep 19, 2025 By Bios Fund I, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 323K $999K $3.09 Jun 13, 2025 By Bios Fund I, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 385K $955K $2.48 Sep 19, 2025 By Bios Memory SPV II, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 327K $810K $2.48 Sep 19, 2025 By Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 84.9K $782K $9.21 Jun 27, 2025 Directly held by BP Directors, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 310K $768K $2.48 Sep 19, 2025 By Bios Fund III, LP
Azitra Inc 10%+ Owner Common Stock 137K $685K $5.00 Jun 21, 2023 Directly held by Bios Fund II NT, LP
Azitra Inc 10%+ Owner Common Stock 136K $679K $5.00 Jun 21, 2023 Direct
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 69.4K $639K $9.21 Jun 27, 2025 Directly held by Circle K Invesco, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 256K $634K $2.48 Sep 19, 2025 By Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 245K $608K $2.48 Sep 19, 2025 By Bios Fund I QP, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 189K $584K $3.09 Jun 13, 2025 By Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 61K $562K $9.21 Jun 27, 2025 Directly held by Aaron G.L. Fletcher
IN8BIO, INC. 10%+ Owner Common Stock 3.73M $559K $0.15 May 2, 2025 By Bios Fund III QP, LP
Cue Biopharma, Inc. Director Common Stock 165K $455K $2.76 May 23, 2022 Direct
Lantern Pharma Inc. 10%+ Owner Common Stock 114K $353K $3.09 Jun 13, 2025 by Bios Fund II, LP
IN8BIO, INC. 10%+ Owner Common Stock 1.88M $281K $0.15 May 2, 2025 By Bios Fund II QP, LP
TFF Pharmaceuticals, Inc. Director Common Stock 542K $212K $0.39 Nov 22, 2022 Indirect
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 78.3K $194K $2.48 Sep 19, 2025 By Bios Fund II, LP
SWK Holdings Corp Director Common Stock 9.87K $177K $17.95 Dec 31, 2021 Direct
Lantern Pharma Inc. 10%+ Owner Common Stock 50K $154K $3.09 Jun 13, 2025 By Bios Fund II NT, LP
IN8BIO, INC. 10%+ Owner Common Stock 997K $150K $0.15 May 2, 2025 By BIOS Incysus Co-Invest I, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 26.1K $101K $3.86 Jun 13, 2025 By BP Directors, LP
IN8BIO, INC. 10%+ Owner Common Stock 602K $90.3K $0.15 May 2, 2025 By Bios Fund III, NT, LP
IN8BIO, INC. 10%+ Owner Common Stock 574K $86.2K $0.15 May 2, 2025 By Bios Fund II, LP
IN8BIO, INC. 10%+ Owner Common Stock 571K $85.6K $0.15 May 2, 2025 By Bios Fund III, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 34.2K $84.9K $2.48 Sep 19, 2025 By Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 8.06K $74.2K $9.21 Jun 27, 2025 Directly held by KF Legacy Trust U/A/D December 7, 2016
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 8.06K $74.2K $9.21 Jun 27, 2025 Directly held by MF Legacy Trust U/A/D December 7, 2016
Azitra Inc 10%+ Owner Common Stock 13.1K $65.5K $5.00 Jun 21, 2023 Directly held by KF Legacy Trust
Azitra Inc 10%+ Owner Common Stock 13.1K $65.5K $5.00 Jun 21, 2023 Directly held by MF Legacy Trust
TFF Pharmaceuticals, Inc. Director Common Stock 143K $56.2K $0.39 Nov 22, 2022 Direct
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 56.2K $47.2K $0.84 Sep 19, 2025 Direct
IN8BIO, INC. 10%+ Owner Common Stock 251K $37.7K $0.15 May 2, 2025 By Bios Fund II NT, LP
Cue Biopharma, Inc. Director Common Stock 8.87K $24.5K $2.76 May 23, 2022 By Spouse
IN8BIO, INC. 10%+ Owner Pre-Funded Warrants 2.43M May 2, 2025 By Bios Clinical Opportunity Fund, LP
IN8BIO, INC. 10%+ Owner Series C Warrant 709K May 2, 2025 By Bios Clinical Opportunity Fund, LP
IN8BIO, INC. 10%+ Owner Stock Option 85K May 2, 2025 Indirect
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 71.4K Jun 27, 2025 Directly held by Bios 2024 Co-Invest, LP
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 33.5K Dec 29, 2022 To BP Directors for the benefit of Reporting Person
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 31.9K Aug 12, 2024 Directly held by BP Directors, LP
TFF Pharmaceuticals, Inc. Director Common Stock Purchase Warrants 21.7K Nov 22, 2022 Direct
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 15K May 22, 2025 Direct
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 15K Aug 12, 2024 Directly held by Aaron G.L. Fletcher
Cue Biopharma, Inc. Director Stock Option (right to buy) 10K Jan 3, 2023 Direct
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Convertible Note 0 Aug 14, 2024 Directly held by Bios Clinical Opportunity Fund, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP
Azitra Inc 10%+ Owner Convertible Notes 0 Jun 21, 2023 Directly held by Bios Fund III, LP
Azitra Inc 10%+ Owner Convertible Notes 0 Jun 21, 2023 Directly held by Bios Fund III NT, LP
Azitra Inc 10%+ Owner Convertible Notes 0 Jun 21, 2023 Directly held by Bios Fund III QP, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Azitra Co-Invest I, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund II, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund II NT, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund II QP, LP
Azitra Inc 10%+ Owner Series A Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund I, LP
Azitra Inc 10%+ Owner Series A Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund I QP, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund III, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund III NT, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund III QP, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund II, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund II NT, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 Jun 21, 2023 Directly held by Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Stock Option (right to buy) 0 Sep 19, 2025 Direct
IN8BIO, INC. 10%+ Owner Series A Warrant 0 May 2, 2025 By Bios Clinical Opportunity Fund, LP
IN8BIO, INC. 10%+ Owner Series B Warrant 0 May 2, 2025 By Bios Clinical Opportunity Fund, LP

Insider Reports Filed by Aaron G.L. Fletcher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGTX COGNITION THERAPEUTICS INC Sep 19, 2025 2 $6.49K 4 Sep 23, 2025 Director, 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Jun 27, 2025 2 $500K 4 Jun 30, 2025 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 18, 2025 1 $0 4 Jun 20, 2025 Director, 10%+ Owner
LTRN Lantern Pharma Inc. Jun 13, 2025 5 -$124K 4 Jun 13, 2025 10%+ Owner
LTRN Lantern Pharma Inc. Jun 10, 2025 15 -$208K 4 Jun 13, 2025 10%+ Owner
LTRN Lantern Pharma Inc. May 27, 2025 15 -$168K 4 May 29, 2025 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. May 22, 2025 1 $0 4 May 23, 2025 Director, 10%+ Owner
[INAB IN8BIO, INC. May 2, 2025 3 $0 4 May 7, 2025 10%+ Owner
INAB IN8BIO, INC. Oct 4, 2024 4 $0 4 Oct 11, 2024 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 3 -$200K 4/A Aug 20, 2024 Director, 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 4 Aug 14, 2024 Director, 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 56 $3.98M 4 Aug 14, 2024 Director, 10%+ Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 3 Aug 12, 2024 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 7, 2024 2 $0 4 Jun 11, 2024 Director, 10%+ Owner
LTRN Lantern Pharma Inc. May 23, 2024 6 -$189K 4 May 28, 2024 10%+ Owner
LTRN Lantern Pharma Inc. Feb 27, 2024 9 -$676K 4 Feb 29, 2024 10%+ Owner
LTRN Lantern Pharma Inc. Jan 17, 2024 9 $1.93 4 Jan 19, 2024 10%+ Owner
NGE C IN8BIO, INC. Dec 13, 2023 3 $0 4 Dec 14, 2023 10%+ Owner
LTRN Lantern Pharma Inc. Nov 29, 2023 2 -$500K 4 Dec 1, 2023 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Nov 8, 2023 1 $525K 4 Nov 13, 2023 Director, 10%+ Owner
AZTR Azitra Inc Jun 21, 2023 33 $3M 4 Jun 23, 2023 10%+ Owner
AZTR Azitra Inc Jun 15, 2023 0 $0 3 Jun 15, 2023 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 9, 2023 2 $0 4 Jun 13, 2023 Director, 10%+ Owner
CUE Cue Biopharma, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
TFFP TFF Pharmaceuticals, Inc. Dec 29, 2022 1 $0 4 Dec 30, 2022 Director
INAB IN8BIO, INC. Dec 12, 2022 3 $186K 4 Dec 13, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Nov 28, 2022 3 $42.6K 4 Nov 29, 2022 Director, 10%+ Owner
TFFP TFF Pharmaceuticals, Inc. Nov 22, 2022 2 $50K 4 Nov 23, 2022 Director
CGTX COGNITION THERAPEUTICS INC Nov 16, 2022 3 $99.4K 4 Nov 17, 2022 Director
CGTX COGNITION THERAPEUTICS INC Nov 15, 2022 3 $1.8M 4 Nov 16, 2022 Director
LTRN Lantern Pharma Inc. Nov 8, 2022 5 -$1.54M 4 Nov 9, 2022 10%+ Owner
INAB IN8BIO, INC. Sep 28, 2022 3 $50.5K 4 Sep 29, 2022 Director, 10%+ Owner
LTRN Lantern Pharma Inc. Sep 2, 2022 6 $0.14 4 Sep 7, 2022 10%+ Owner
INAB IN8BIO, INC. Aug 26, 2022 6 $103K 4 Aug 30, 2022 Director, 10%+ Owner
INAB IN8BIO, INC. Aug 17, 2022 3 $96.5K 4 Aug 18, 2022 Director, 10%+ Owner
INAB IN8BIO, INC. Aug 16, 2022 3 $3.37M 4 Aug 17, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 10, 2022 3 $0 4/A Jun 30, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Jun 10, 2022 3 $0 4 Jun 14, 2022 Director, 10%+ Owner
CUE Cue Biopharma, Inc. May 23, 2022 2 $712K 4 May 25, 2022 Director
TFFP TFF Pharmaceuticals, Inc. May 16, 2022 2 $538K 4 May 17, 2022 Director
TFFP TFF Pharmaceuticals, Inc. Apr 4, 2022 2 $3.5M 4 Apr 4, 2022 Director
CUE Cue Biopharma, Inc. Mar 31, 2022 1 $3.5M 4 Apr 4, 2022 Director
CGTX COGNITION THERAPEUTICS INC Jan 31, 2022 2 $0 4 Feb 1, 2022 Director, 10%+ Owner
CUE Cue Biopharma, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
SWKH SWK Holdings Corp Dec 31, 2021 1 $0 4 Jan 12, 2022 Director
SWKH SWK Holdings Corp Dec 31, 2021 1 $0 4 Jan 3, 2022 Director
CGTX COGNITION THERAPEUTICS INC Oct 13, 2021 1 $0 4/A Feb 1, 2022 Director, 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Oct 7, 2021 0 $0 3/A Feb 1, 2022 Director, 10%+ Owner
SWKH SWK Holdings Corp Sep 30, 2021 2 $0 4 Oct 1, 2021 Director
INAB IN8BIO, INC. Aug 13, 2021 2 $0 4 Aug 17, 2021 10%+ Owner
INAB IN8BIO, INC. Aug 3, 2021 14 $0 4 Aug 3, 2021 10%+ Owner
INAB IN8BIO, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 10%+ Owner
SWKH SWK Holdings Corp Jun 30, 2021 1 $0 4 Jun 30, 2021 Director